Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Fuchs

Showing results (201-210 of 257) with videos related to

Pageof 26
Sort By:
Clinical Therapeutics|January 1, 1980
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of EnterobacteriaceaeP C Fuchs, A L Barry, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1992
Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family EnterobacteriaceaeA L Barry, P C Fuchs, E H Gerlach, et al.
Journal of Clinical Microbiology|January 1, 1995
Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628A L Barry, P C Fuchs, S D Allen, et al.
Journal of Clinical Microbiology|April 1, 1987
Antimicrobic susceptibility and plasmid profile analysis as identity tests for multiple blood isolates of coagulase-negative staphylococciA I Hartstein, M A Valvano, V H Morthland, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactamM A Pfaller, A L Barry, P C Fuchs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosaD J Hardy, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteriaP R Murray, R N Jones, S D Allen, et al.
Pageof 26

Showing results (201-210 of 257) with videos related to

Sort By:
Pageof 26
Clinical Therapeutics|January 1, 1980
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of EnterobacteriaceaeP C Fuchs, A L Barry, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1992
Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family EnterobacteriaceaeA L Barry, P C Fuchs, E H Gerlach, et al.
Journal of Clinical Microbiology|January 1, 1995
Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628A L Barry, P C Fuchs, S D Allen, et al.
Journal of Clinical Microbiology|April 1, 1987
Antimicrobic susceptibility and plasmid profile analysis as identity tests for multiple blood isolates of coagulase-negative staphylococciA I Hartstein, M A Valvano, V H Morthland, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactamM A Pfaller, A L Barry, P C Fuchs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosaD J Hardy, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteriaP R Murray, R N Jones, S D Allen, et al.
Pageof 26